City
Epaper

Canada to donate 17.7mn AstraZeneca vax to other countries

By IANS | Updated: July 13, 2021 09:40 IST

Ottawa, July 13 Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to ...

Open in App

Ottawa, July 13 Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to low- and middle-income countries.

While addressing a press conference on Monday, Procurement Minister Anita Anand said that the vaccine doses are a part of the Canadian government's advance purchase agreement with the company and would be distributed through COVAX, reports Xinhua news agency.

COVAX is a global vaccine-sharing initiative jointly co-ordinated by the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance.

"This donation is a result of our proactive approach to securing hundreds of millions of Covid-19 vaccines in our initial contracts. With close to 55 million vaccines in Canada, and with the demands of the provinces and territories for this vaccine being met, we are now in a position to donate these excess doses," Anand said.

The government also announced it's partnering with Unicef on a donation-matching fundraising campaign to encourage Canad to donate vaccine doses by contributing C$10.

All donations by Canad will be matched by the federal government, up to a maximum of C$10 million).

The campaign runs until September 6.

Anand said that if the Unicef campaign is maxed out, it will provide enough money to vaccinate 4 million people in countries where inoculation campaigns are struggling to meet demand.

She said that the AstraZeneca doses are coming from the advance purchase agreement the government struck with the company and that these doses, which will be manufactured in the United States, will start being delivered to COVAX in the coming weeks.

The Public Health Agency of Canada and the National Advisory Committee on Immunization have "recommended" mRNA vaccines such as Moderna or Pfizer over AstraZeneca's product.

The recommendation was made in the wake of evidence suggesting that, in rare cases, the AstraZeneca vaccine could cause potentially fatal blood clots in some people.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Anita AnandcanadaXinhuaOttawaAstrazenecaIndia canadaAstrazeneca plc.Astrazeneca plcAstra zenecaRoche company
Open in App

Related Stories

NationalPM Narendra Modi Leaves for Croatia After Concluding ‘Productive’ Canada Visit

International'Playing for Peace': Cristiano Ronaldo Sends Jersey With Message to Donald Trump Amid Israel-Iran Conflict

MumbaiMumbai: Man Trying to Fly with Fake UAE Visa Held at CSMI Airport

InternationalPakistani National Accused in Plot to Shoot New York Jewish Centre Extradited From Canada to US

MumbaiBaba Siddique Murder Mastermind Zeeshan Akhtar Detained in Canada, Says Mumbai Police

Politics Realted Stories

NationalAssembly Bypoll Results 2025: AAP Wins Visavadar and Ludhiana West Seats; Congress Wrests Nilambur Seat in Kerala

MaharashtraNCP Leader Suraj Chavan Shares Alleged Black Magic Video of Shiv Sena Leader Bharat Gogawle Amid Row Over Raigad Guardian Post

MaharashtraMaharashtra Politics: Raj Thackeray Meets CM Devendra Fadnavis at Taj Lands End Amid Rumours of MNS–Sena UBT Alliance

MaharashtraMaharashtra Municipal Elections 2025: Mahayuti Alliance to Contest Civic Body Polls Together, Says CM Devendra Fadnavis

Maharashtra'Remembered the Advice My Mother Gave Me': Supriya Sule On Her WhatsApp Status